Evaluation of sleep quality, sleepiness, and quality of life in patients with scabies: A case-control study Skabiyez hastalarında uyku kalitesi, uykululuk ve yaşam kalitesinin değerlendirilmesi: Bir olgu-kontrol çalışması

Creative Commons License

Düzayak S., Kurt B. Ö.

Turkderm Turkish Archives of Dermatology and Venereology, cilt.60, sa.2, ss.67-73, 2026 (ESCI, Scopus, TRDizin)

Özet

Background and Design: Scabies is a contagious skin disease characterized by itching, especially severe at night. This study aimed to evaluate sleep quality, sleepiness, and quality of life (QoL) using valid scales in patients with scabies and to identify the factors affecting these parameters. Materials and Methods: This case-control study included 61 patients with scabies and 66 age- and sex-matched volunteers. The Turkish versions of the Pittsburgh Sleep Quality Index (PSQI), Epworth sleepiness scale (ESS), Children’s Dermatology Life Quality Index (CDLQI), and Dermatology Life Quality Index (DLQI) were used. Results: The CDLQI was >12 in 55.56% of adolescents under 16 years, the DLQI was >10 in 63.46% of patients aged 16 years and over, and the PSQI was >5 in 81.97% of patients. The mean scores of the CDLQI, DLQI, ESS, PSQI global, and PSQI subgroups were significantly higher in the patient group than in the control group (p<0.05). The rates of CDLQI >12, DLQI >10, and PSQI >5 were higher in the patient group than in the control group (p<0.05). The scabies group had higher mean PSQI global scores, higher rates of patients with PSQI >5, higher mean ESS scores, and higher rates of patients with ESS >10 compared to the unaffected group (p<0.05). Conclusion: Scabies is associated with decreased sleep quality, increased sleepiness, and impaired QoL. Patients with scabies have neglected psychosocial and physiological burdens, resulting in impaired QoL and sleep.